BSE Live
Mar 28, 15:40Prev. Close
3.21
Open Price
3.26
Bid Price (Qty.)
3.10 (100)
Offer Price (Qty.)
3.26 (1000)
NSE Live
Mar 28, 15:31Prev. Close
3.30
Open Price
3.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sharon Bio Medicine (in Rs. Cr.) | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Jun 14 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -8.49 | -29.25 | -25.16 | -16.97 | 5.23 | |
| Diluted EPS (Rs.) | -8.49 | -29.25 | -19.38 | -11.91 | 3.69 | |
| Cash EPS (Rs.) | -7.62 | -27.89 | -23.89 | -17.37 | 8.05 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -53.41 | -44.92 | -15.26 | 9.90 | 32.55 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -53.41 | -44.92 | -15.26 | 9.93 | 32.58 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | |
| Revenue from Operations/Share (Rs.) | 10.80 | 11.67 | 21.31 | 70.12 | 124.45 | |
| PBDIT/Share (Rs.) | 0.53 | -12.22 | -11.09 | -2.66 | 15.04 | |
| PBIT/Share (Rs.) | -0.37 | -13.58 | -12.35 | -4.28 | 13.58 | |
| PBT/Share (Rs.) | -8.52 | -29.05 | -24.32 | -18.60 | 8.03 | |
| Net Profit/Share (Rs.) | -8.52 | -29.25 | -25.16 | -18.99 | 6.59 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 4.90 | -104.71 | -52.03 | -3.79 | 12.08 | |
| PBIT Margin (%) | -3.39 | -116.33 | -57.96 | -6.10 | 10.91 | |
| PBT Margin (%) | -78.85 | -248.92 | -114.11 | -26.52 | 6.45 | |
| Net Profit Margin (%) | -78.85 | -250.61 | -118.05 | -27.08 | 5.29 | |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | -191.87 | 20.26 | |
| Return on Capital Employed (%) | 1.92 | 452.66 | -38.14 | -34.76 | 10.77 | |
| Return on Assets (%) | -40.33 | -98.37 | -41.39 | -22.32 | 5.99 | |
| Total Debt/Equity (X) | -1.00 | -1.36 | -4.61 | 6.98 | 2.11 | |
| Asset Turnover Ratio (%) | 0.00 | 0.26 | 35.06 | 82.44 | 113.16 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.12 | 0.14 | 1.17 | 1.85 | 1.59 | |
| Quick Ratio (X) | 0.08 | 0.09 | 0.64 | 1.02 | 0.97 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.78 | 1.41 | 2.77 | 4.07 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 5.45 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 4.47 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 94.55 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 95.53 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 956.40 | 954.36 | 1,221.95 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 3.77 | 1.14 | 0.93 | |
| EV/EBITDA (X) | 0.00 | 0.00 | -7.25 | -30.15 | 7.70 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.51 | 0.18 | 0.39 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 94.54 | |
| Price/BV (X) | 0.00 | 0.00 | -0.72 | 1.27 | 1.48 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.51 | 0.18 | 0.39 | |
| Earnings Yield | 0.00 | 0.00 | -2.30 | -1.51 | 0.14 |
31.05.2023
Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y
12.02.2023
Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y
18.05.2022
Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y
07.02.2022
Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y
31.05.2023
Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y
12.02.2023
Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y
18.05.2022
Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y
07.02.2022
Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y